A woman with a history of infertility is on treatment with human menopausal gonadotropin. She presented with the following finding in the USG. What is the most likely diagnosis ?

Explanation

## Correct Answer: C. Ovarian hyperstimulation syndrome Ovarian hyperstimulation syndrome (OHSS) is the most likely diagnosis in a woman on human menopausal gonadotropin (hMG) therapy presenting with USG findings of enlarged ovaries with multiple cysts. OHSS occurs due to exaggerated ovarian response to gonadotropin stimulation, leading to excessive estrogen and progesterone production. The pathophysiology involves release of vasoactive substances (particularly VEGF and cytokines) from granulosa cells, causing increased vascular permeability, fluid shift from intravascular to third space, and ovarian enlargement. Clinical presentation includes abdominal distension, pain, nausea, and in severe cases, ascites, pleural effusion, and hemoconcentration. USG characteristically shows bilateral ovarian enlargement (often >5 cm), multiple follicles/cysts, and free fluid in pelvis. The condition is iatrogenic, directly related to gonadotropin dosing and ovarian sensitivity. Mild OHSS is self-limiting and managed conservatively; severe OHSS requires hospitalization, fluid management, and electrolyte monitoring. This is a well-recognized complication of assisted reproductive technology (ART) in Indian fertility centers. ## Why the other options are wrong **A. Theca lutein cyst** — Theca lutein cysts are benign, hormone-responsive cysts that develop from theca interna cells and are typically associated with high hCG states (molar pregnancy, choriocarcinoma, or multiple gestations). While they can occur with gonadotropin stimulation, they are usually unilateral or less prominent than OHSS findings. The clinical context of infertility treatment with hMG and bilateral ovarian enlargement with multiple cysts is pathognomonic for OHSS, not theca lutein cysts. **B. None** — This is a distractor option. The patient clearly has a pathological condition evident on USG with a clear clinical context of gonadotropin exposure. Dismissing the findings as 'none' ignores the iatrogenic complication of fertility treatment and would delay recognition and management of a potentially serious condition. **D. Polycystic ovarian syndrome** — PCOS presents with chronic anovulation, insulin resistance, and hyperandrogenism, with USG showing multiple small follicles (2–9 mm) in a 'string of pearls' pattern bilaterally. However, PCOS is a chronic endocrine disorder, not an acute iatrogenic complication. The acute presentation following hMG therapy, bilateral ovarian enlargement with larger cysts, and systemic symptoms (abdominal distension, pain) are inconsistent with PCOS and point to OHSS instead. ## High-Yield Facts - **OHSS pathophysiology**: Exaggerated ovarian response to gonadotropins → excessive estrogen/progesterone → VEGF release → increased vascular permeability → third-space fluid shift. - **OHSS risk factors**: High baseline AFC, young age, low BMI, PCOS, previous OHSS, high hCG (pregnancy), and high gonadotropin doses. - **Mild vs Severe OHSS**: Mild OHSS (abdominal pain, mild distension, nausea) is self-limiting; Severe OHSS (ascites, pleural effusion, oliguria, hemoconcentration, thrombosis) requires hospitalization. - **USG findings in OHSS**: Bilateral ovarian enlargement (>5 cm), multiple follicles/cysts, free fluid in pelvis, and occasionally ascites. - **Management of OHSS**: Mild—conservative (rest, hydration, NSAIDs); Severe—hospitalization, IV fluids, electrolyte monitoring, coagulation profile, and consideration of paracentesis if symptomatic ascites. - **Prevention in Indian fertility centers**: Individualized gonadotropin dosing, GnRH agonist trigger instead of hCG, and cycle cancellation if excessive response detected. ## Mnemonics **OHSS Severity (MILD vs SEVERE)** **MILD**: Mild pain, nausea, mild distension, normal labs. **SEVERE**: Severe pain, vomiting, ascites, oliguria, hemoconcentration, thrombosis risk. Use this to triage management—mild is outpatient, severe is ICU-level care. **OHSS vs PCOS (Quick Discriminator)** **OHSS**: Acute onset post-gonadotropin, bilateral large cysts, systemic symptoms, self-limiting. **PCOS**: Chronic, small follicles ('pearls'), metabolic syndrome, anovulation. Remember: OHSS is *iatrogenic and acute*; PCOS is *endocrine and chronic*. ## NBE Trap NBE may pair "theca lutein cyst" with gonadotropin therapy to trap students who conflate hormone-responsive cysts with OHSS. The key discriminator is the acute bilateral ovarian enlargement with systemic symptoms (abdominal distension, pain) in the context of hMG stimulation—this is OHSS, not a benign cyst. ## Clinical Pearl In Indian fertility centers, OHSS is a recognized complication of ART cycles. A woman presenting with acute abdominal pain, distension, and nausea during or immediately after hMG stimulation should raise suspicion for OHSS. Early recognition prevents progression to severe OHSS with ascites, thrombosis, and renal dysfunction—a potentially life-threatening condition requiring ICU-level care. _Reference: DC Dutta's Textbook of Obstetrics (Ch. 10: Assisted Reproductive Technology); Harrison's Principles of Internal Medicine (Ch. 405: Infertility and Reproductive Endocrinology)_